Research
Research groups
Research projects
Active projects
Researchers:
Publications
203 publications
Page 2 of 21
E. Sally Ward, Wei Sun , Priyanka Khare, Xiaoli Wang, Dilip K. Challa, Benjamin M. Greenberg & R.J. Ober,
2020, Molecular Therapy, 29(3)
Type: article
Adrian C. Newland, Blanca Sánchez‐González, László Rejtő, Miklos Egyed, Nataliya Romanyuk, Marie Godar, Katrien Verschueren, Domenica Gandini, Peter Ulrichts, Jon Beauchamp, Torsten Dreier, E. Sally Ward, Marc Michel, Howard A. Liebman, Hans Haard, Nicolas Leupin & David J. Kuter,
2020, American Journal of Hematology, 95(2), 178-187
DOI: 10.1002/ajh.25680
Type: article
James F. Howard, Vera Bril, Ted M. Burns, Renato Mantegazza, Malgorzata Bilinska, Andrzej Szczudlik, Said Beydoun, Francisco Javier Rodriguez De Rivera Garrido, Fredrick Piehl, Mariarosa Rottoli, Phillip Van Damme, Tuan Vu, Amelia Evoli, Miriam Freimer, Tahseen Mozaffar, E. Sally Ward, Torsten Dreier, Peter Ulrichts, Katrien Verschueren, Antonio Guglietta, Hans de Haard, Nicolas Leupin & Jan J.G.M. Verschuuren,
2019, Neurology, 92(23), 2661-2673
Type: article
Dilip K. Challa, Xiaoli Wang, Hector Pérez Montoyo, Ramraj Velmurugan, R.J. Ober & E. Sally Ward,
2019, mAbs
Type: article
Jeffrey C. Kang, Wei Sun, Priyanka Khare, Mostafa Karimi, Xiaoli Wang, Yang Shen, R.J. Ober & E. Sally Ward,
2019, Nature Biotechnology, 37(5), 523-526
Type: article
Peter Ulrichts, Antonio Guglietta, Torsten Dreier, Tonke van Bragt, Valérie Hanssens, Erik Hofman, Bernhardt Vankerckhoven, Peter Verheesen, Nicolas Ongenae, Valentina Lykhopiy, F Javier Enriquez, JunHaeng Cho, Raimund J Ober, E. Sally Ward, Hans de Haard & Nicolas Leupin,
2018, Journal of Clinical Investigation, 128(10), 4372-4386
DOI: 10.1172/JCI97911
Type: article
E. Sally Ward & Raimund J. Ober,
2018, Trends in Pharmacological Sciences, 39(10), 892-904
Type: article
Krystin Deason, Ty Dale Troutman, Aakanksha Jain, Dilip K Challa, Rajakumar Mandraju, Travis Brewer, E Sally Ward & Chandrashekhar Pasare,
2018, The Journal of Experimental Medicine, 215(9), 2413-2428
DOI: 10.1084/jem.20171810
Type: article
Ramraj Velmurugan, Sreevidhya Ramakrishnan, Mingin Kim, Raimund J. Ober & E. Sally Ward,
2018, Traffic, 19(4), 273-284
DOI: 10.1111/tra.12552
Type: article
Ran Li, Srinivas Chiguru, Li Li, Dongyoung Kim, Ramraj Velmurugan, David Kim, Siva Charan Devanaboyina, Hong Tian, Alan Schroit, Ralph P. Mason, Raimund J. Ober & E. Sally Ward,
2018, Molecular Cancer Therapeutics, 17(1), 169-182
Type: article
External roles and responsibilities
Name:
Vice President, The Antibody Society.
Role:
Participant
Year:
2020
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimization and Development Core Facility (Program leader: Zhiqiang An, Houston, TX).
Role:
Participant
Year:
2015
Name:
Board of Directors, Antibody Society.
Role:
Participant
Year:
2019
Name:
Gordon Research Conference (‘Antibody Biology and Engineering’), Il Ciocco, Italy (discussion leader).
Role:
Speaker
Year:
2014
Name:
New York Academy of Sciences Symposium ‘Hot technologies for generating next-gen biologics’, New York, NY (invited speaker).
Role:
Speaker
Year:
2014
Name:
FASEB Science Research Conference (‘Immunoreceptors’) Steamboat Springs, CO (invited speaker).
Role:
Speaker
Year:
2014
Name:
Texas FreshAIR Annual Conference, Houston, TX (invited speaker).
Role:
Speaker
Year:
2014
Name:
MD Anderson Cancer Center, Houston, TX (invited speaker).
Role:
Speaker
Year:
2015
Name:
Antibodies: an evolving force in cancer treatment, Royal Society of Medicine, London, UK (invited speaker).
Role:
Speaker
Year:
2015
Name:
2nd Texas A&M Eng-Life Symposium, Texas A&M University, TX (Keynote address).
Role:
Speaker
Year:
2015
Name:
Distinguished Lecture Series, Department of Experimental Therapeutics, MD Anderson Cancer Centre, Houston, TX, (virtual presentation).
Role:
Speaker
Year:
2021
Name:
15th Beaune Seminar in Transplant Research, Beaune, France (invited speaker).
Role:
Speaker
Year:
2015
Name:
Gordon Research Conference (‘Drug Metabolism’), Holderness, NH (invited speaker).
Role:
Speaker
Year:
2015
Name:
3rd Antibody and Protein Therapeutics Conference, Boston, MA (Keynote address).
Role:
Speaker
Year:
2015
Name:
Fourth AACR International Conference on Frontiers in Basic Cancer Research, Phildelphia, PA (invited talk).
Role:
Speaker
Year:
2015
Name:
Peptalk Cancer Immunotherapy Conference, San Diego, CA (invited speaker).
Role:
Speaker
Year:
2016
Name:
Gordon Research Conference (‘Antibody Biology and Engineering’), Galveston, TX (Keynote address).
Role:
Speaker
Year:
2016
Name:
FASEB Science Research Conference (‘Immunoreceptors’) Snowmass, CO (invited speaker).
Role:
Speaker
Year:
2016
Name:
Amgen, Thousand Oaks, CA (invited speaker).
Role:
Speaker
Year:
2016
Name:
Congress of GFHT and CoMETH, Tours, France (invited speaker).
Role:
Speaker
Year:
2016
Name:
GTCbio’s 4th Antibody and Protein Therapeutics Conference, Boston, MA (invited speaker).
Role:
Speaker
Year:
2016
Name:
Quantitative Bioimaging (QBI) Conference, Texas A&M University, College Station, TX (invited speaker).
Role:
Speaker
Year:
2017
Name:
Selectbio’s Antibodies in Drug Discovery, Hinxton, Cambridge, UK (Keynote address).
Role:
Speaker
Year:
2017
Name:
GTCbio’s Antibody and Protein Therapeutics Conference, Baltimore, MD (keynote address).
Role:
Speaker
Year:
2017
Name:
CPRIT Therapeutic Antibody Symposium, The Brown Foundation Institute of Molecular Medicine, Houston, TX (keynote address).
Role:
Speaker
Year:
2017
Name:
17th Annual Peptalk-the Protein Science Week, San Diego, CA (invited speaker).
Role:
Speaker
Year:
2018
Name:
Human Immunology-Technology Initiative in Lupus (Lupus Research Alliance), Miami, FL (invited speaker).
Role:
Speaker
Year:
2018
Name:
Histochemical Society Annual Meeting at Experimental Biology 2018, San Diego, CA (invited speaker).
Role:
Speaker
Year:
2018
Name:
4th Annual PEGS Conference, Boston, MA (keynote address).
Role:
Speaker
Year:
2018
Name:
Selectbio’s Antibodies in Drug Discovery, Cambridge, UK (invited speaker).
Role:
Speaker
Year:
2018
Name:
FASEB Science Research Conference (‘Immunoreceptors and Immunotherapy’), Snowmass, CO (session speaker).
Role:
Speaker
Year:
2018
Name:
Bioengineering Departmental Seminar, University of Texas at Arlington, Arlington, TX (invited speaker).
Role:
Speaker
Year:
2018
Name:
CPRIT Therapeutic Antibody Core Symposium, Houston, TX (invited speaker).
Role:
Speaker
Year:
2018
Name:
Quantitative Bioimaging Conference, Rennes, France (invited speaker).
Role:
Speaker
Year:
2019
Name:
Antibody Engineering and Therapeutics Europe, Amsterdam, Netherlands (invited speaker).
Role:
Speaker
Year:
2019
Name:
Affinity 2019, Stockholm, Sweden (keynote address).
Role:
Speaker
Year:
2019
Name:
CDD-MRC Conference (‘Cancer, Immunity and Inflammation'), Cambridge, UK (invited speaker).
Role:
Speaker
Year:
2019
Name:
French Society for Immunology, Club Anticorps meeting, Paris, France (keynote address).
Role:
Speaker
Year:
2019
Name:
Annual Symposium of the Center for Targeted Therapeutics and Translational Medicine, Penn Medicine/Penn Engineering, University of Pennsylvania, Philadelphia, PA (keynote address).
Role:
Speaker
Year:
2019
Name:
Biology and Biosciences Department, University of Bath, UK (invited speaker).
Role:
Speaker
Year:
2020
Name:
Antibody Engineering and Therapeutics conference, Asia, Kyoto, Japan (keynote address).
Role:
Speaker
Year:
2020
Name:
Oxford Global, Biologics Series 2020, London, UK (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
16th Annual PEGS, Boston, MA (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
Antibody Engineering and Therapeutics Conference, Europe (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
11th Annual World ADC, San Diego, CA (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
PEGS Europe, Protein and Antibody Engineering Summit, Lisbon, Portugal (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
Quantitative Bioimaging Conference, Oxford, UK (invited speaker).
Role:
Speaker
Year:
2020
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimization and Development Core Facility (Program leader: Zhiqiang An, Houston, TX).
Role:
Participant
Year:
2016
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimization and Development Core Facility (Program leader: Zhiqiang An, Houston, TX).
Role:
Participant
Year:
2017
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimization and Development Core Facility, (Program leader: Zhiqiang An), Houston, TX.
Role:
Participant
Year:
2018
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimisation and Development Core Facility (Program leader: Zhiqiang An, Houston, TX).
Role:
Participant
Year:
2020
Name:
Antibody Engineering and Therapeutics conference, San Diego, CA (Keynote address).
Role:
Speaker
Year:
2018
Name:
Scientific Advisory Board for Antibody Biology and Engineering Gordon Research Conference.
Role:
Participant
Year:
2017
Name:
Scientific Advisory Board for Antibody Biology and Engineering Gordon Research Conference.
Role:
Participant
Year:
2018
Name:
Scientific Advisory Board for Antibody Biology and Engineering Gordon Research Conference.
Role:
Participant
Year:
2019
Name:
Scientific Advisory Board for Antibody Biology and Engineering Gordon Research Conference.
Role:
Participant
Year:
2020
Name:
10th Annual World ADC London, UK (invited speaker).
Role:
Speaker
Year:
2020
Name:
10th Annual World ADC London, UK (workshop speaker).
Role:
Speaker
Year:
2020
Name:
Member, Fellowship Review Committee, National Multiple Sclerosis Society. (External organisation)
Role:
Participant
Year:
2015
Name:
Member, Fellowship Review Committee, National Multiple Sclerosis Society. (External organisation)
Role:
Participant
Year:
2014
Name:
Distinguished Lecture Series,Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX (invited seminar: virtual presentation).
Role:
Speaker
Year:
2021
Name:
PEGS Boston Summit, Boston, MA (session chair and invited speaker; virtual conference).
Role:
Speaker
Year:
2021
Name:
Nordic POP and FinPharmaNet Meeting, Kuopio, Finland (Keynote address; virtual conference).
Role:
Speaker
Year:
2021
Name:
From laboratory to the clinic: novel approaches to unmet needs, Trinity College, Oxford (invited speaker).
Role:
Speaker
Year:
2021
Name:
B and T cell mediated autoimmune disease drug development summit (invited speaker; virtual conference).
Role:
Speaker
Year:
2021
Name:
PEGS Europe: Protein and Antibody Engineering Summit, Barcelona, Spain (session chair).
Role:
Speaker
Year:
2021
Name:
Festival of Biologics European Antibody Congress 2021, Basel, Switzerland (invited speaker).
Role:
Speaker
Year:
2021
Name:
Department of Pharmaceutical Science, SUNY Buffalo, Buffalo, NY (invited seminar; virtual presentation).
Role:
Speaker
Year:
2021
Name:
VIB Conference (‘Translational Immunology’), Ghent, Belgium (invited speaker).
Role:
Speaker
Year:
2021
Name:
Antibody Engineering and Therapeutics conference, San Diego, CA (session chair).
Role:
Speaker
Year:
2021
Name:
Gordon Research Conference, ‘Antibody Biology and Engineering’, Ventura, CA
Role:
Speaker
Year:
2022
Name:
Department of Immunology, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Role:
Speaker
Year:
2023
Name:
Festival of Biologics USA, San Diego, CA.
Role:
Speaker
Year:
2023
Name:
Antibody Engineering and Therapeutics Europe, Amsterdam, Netherlands.
Role:
Speaker
Year:
2023
Name:
World Congress in Pharmacology, Glasgow, UK.
Role:
Speaker
Year:
2023
Name:
Amsterdam Immunogenicity and Tolerance Seminar, Amsterdam, Netherlands
Role:
Speaker
Year:
2023
Name:
Antibody Engineering and Therapeutics conference, San Diego, CA.
Role:
Speaker
Year:
2023
Name:
Keystone meeting, ‘Antibodies as Drugs: The Art in Antibody Engineering’, Breckenridge, CO.
Role:
Speaker
Year:
2024
Name:
FASEB Science Research Conference, ‘Immunoreceptors and Immunotherapy’, Minneapolis-St. Paul, MN.
Role:
Speaker
Year:
2024
Name:
From the Laboratory to the Clinic: 25 Years of Biological Therapy’, Oxford, UK.
Role:
Speaker
Year:
2024
Name:
Keystone meeting, ‘Antibodies as Drugs: Innovative Formats, Design and Engineering’, Keystone, CO.
Role:
Speaker
Year:
2025
Name:
Sydney Antibody Therapeutics 2025, Sydney, Australia (Keynote address).
Role:
Speaker
Year:
2025
Biography
Prizes
- Royal Society Wolfson Research Merit Award. (2018)
- Royal Society Wolfson Research Merit Award. (2019)
- Royal Society Wolfson Research Merit Award. (2020)
- Royal Society Wolfson Research Merit Award. (2018)
- Royal Society Wolfson Research Merit Award. (2019)
- Royal Society Wolfson Research Merit Award. (2020)
- Fellow of the Royal Society (2022)
- Established Investigator Award (1997)
- International Society of Molecular Recognition Award in Affinity Technology (2025)